SINGAPORE,March 5,2025-- In a significant development for the clinical diagnostics landscape in Singapore,Angsana Molecular & Diagnostics Laboratory (Angsana) and Pathnova Laboratories (Pathnova)
Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024
NEW YORK,March 5,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight
HIGHLIGHTS Safety Review Committee (SRC) meeting confirms end of the Dose Escalation Phase and commencement of the Cohort Expansion Phase (Phase II stage) of the SECuRE study.
By using Neuchips\' Viper series cards,the collaboration also delivers power efficiency and offline LLMs to bring enterprises maximum privacy and security.
The Only Mobile Measurement Partner (MMP) To Offer Advanced Data Protection Meeting HIPPA Requirements
